Table 1.
Comparison of clinical characteristics of COVID-19 survivors at baseline assessment and non-COVID controls
| Characteristic | COVID-19 survivors | Non-COVID controls | P value |
|---|---|---|---|
| Number | 52 | 50 | |
| Age, yr | 61.2±8.8 | 59.8±3.5 | 0.304 |
| Male sex | 26 (50.0) | 23 (46.0) | 0.686 |
| BMI, kg/m2 | 24.6±3.1 | 23.9±2.9 | 0.236 |
| Fasting glucose, mmol/L | 5.1±0.5 | 5.1±0.4 | 0.997 |
| HbA1c, % | 5.5±0.3 | 5.6±0.3 | 0.894 |
| HOMA-IRa | 1.40 (0.94–2.32) | 1.18 (0.90–1.80) | 0.065 |
| HOMA-βa | 89.6 (61.8–122.0) | 65.1 (48.4–101.8) | 0.047 |
| C-peptidea, nmol/L | 0.66 (0.56–0.83) | 0.52 (0.45–0.66) | 0.001 |
Values are presented as mean±standard deviation, number (%), or median (interquartile range).
COVID-19, coronavirus disease 2019; BMI, body mass index; HbA1c, glycosylated hemoglobin; HOMA-IR, homeostasis model assessment of insulin resistance; HOMA-β, homeostasis model assessment of β-cell function.
a
Logarithmically transformed before analyses.